TTF-1 and Napsin A Double Stain A Useful Marker for Diagnosing Lung Adenocarcinoma on Fine-Needle Aspiration Cell Blocks

被引:59
作者
Fatima, Nazneen [1 ]
Cohen, Cynthia [1 ]
Lawson, Diane [1 ]
Siddiqui, Momin T. [1 ]
机构
[1] Emory Univ Hosp, Dept Pathol, Atlanta, GA 30322 USA
关键词
TTF-1; napsin A; lung cancer; immunohistochemistry; cell blocks; fine-needle aspiration; TRANSCRIPTION FACTOR-I; PULMONARY ADENOCARCINOMA; PLEURAL EFFUSIONS; CANCER; CARCINOMA; BEVACIZUMAB; CARBOPLATIN; PACLITAXEL;
D O I
10.1002/cncy.20135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Immunohistochemistry (IHC) for thyroid transcription factor-1 (TTF-1) is used to confirm the diagnosis of lung adenocarcinoma. Napsin A also has shown positivity in lung adenocarcinoma. A combined double stain for TTF-1 and napsin A has been proposed to achieve higher sensitivity and specificity. In this study, the authors evaluated the utility of this double stain in the diagnosis of lung adenocarcinoma in cell blocks of fine-needle aspirates (FNA). METHODS: The authors used a cohort comprising 35 FNA cell blocks of lung adenocarcinoma and 24 FNA cell blocks of lung squamous cell carcinoma (SqCCA). IHC was performed; expressions of TTF-1 as brown nuclear stain and of napsin A as red cytoplasmic stain were identified. RESULTS: Twenty-six of 35 (74%) lung adenocarcinomas were positive for double staining with TTF-1/napsin A. Of 35 lung adenocarcinomas, only 2 (5%) were positive for TTF-1 alone and 3 (8%) were positive for napsin A alone. For the double stain TTF-1/napsin A, 3 of 24 (12%) lung SqCCAs were positive for both. Six of 24 (25%) cases were positive for TTF-1 alone, and none were positive for napsin A alone. For lung adenocarcinoma, TTF-1/napsin A has a sensitivity of 74%, specificity of 87%, accuracy of 79%, and a positive predictive value of 89%. CONCLUSIONS: The double IHC stain, TTF-1/napsin A, for the identification of pulmonary adenocarcinoma in FNA cell block materials was diagnostically useful. The use of napsin A alone demonstrated a greater degree of accuracy and appeared diagnostically useful as a single IHC stain. Cancer (Cancer Cytopathol) 2011;119:127-33. (C) 2011 American Cancer Society.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 28 条
[1]   Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma [J].
Bishop, Justin A. ;
Sharma, Rajni ;
Illei, Peter B. .
HUMAN PATHOLOGY, 2010, 41 (01) :20-25
[2]   FDA drug approval summary:: Bevacizumab (Avastin®) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer [J].
Cohen, Martin H. ;
Gootenberg, Joe ;
Keegan, Patricia ;
Pazdur, Richard .
ONCOLOGIST, 2007, 12 (06) :713-718
[3]   Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions [J].
Dejmek, Annika ;
Naucler, Pontus ;
Smedjeback, Anita ;
Kato, Harubumi ;
Maeda, Masahiro ;
Yashima, Koichi ;
Maeda, Junichi ;
Hirano, Takashi .
DIAGNOSTIC CYTOPATHOLOGY, 2007, 35 (08) :493-497
[4]   Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category [J].
Edwards, SL ;
Roberts, C ;
McKean, ME ;
Cockburn, JS ;
Jeffrey, RR ;
Kerr, KM .
JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (07) :537-540
[5]   Estimates of the cancer incidence and mortality in Europe in 2006 [J].
Ferlay, J. ;
Autier, P. ;
Boniol, M. ;
Heanue, M. ;
Colombet, M. ;
Boyle, P. .
ANNALS OF ONCOLOGY, 2007, 18 (03) :581-592
[6]   Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma [J].
Harlamert, HA ;
Mira, J ;
Bejarano, PA ;
Baughman, RP ;
Miller, MA ;
Whitsett, JA ;
Yassin, R .
ACTA CYTOLOGICA, 1998, 42 (06) :1382-1388
[7]  
Hecht JL, 2001, AM J CLIN PATHOL, V116, P483
[8]   The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer A Literature Review [J].
Hirsch, Fred R. ;
Spreafico, Anna ;
Novello, Silvia ;
Wood, Mary Dugan ;
Simms, Lorinda ;
Papotti, Mauro .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (12) :1468-1481
[9]  
Jagirdar J, 2008, ARCH PATHOL LAB MED, V132, P384, DOI 10.1043/1543-2165(2008)132[384:AOITTD]2.0.CO
[10]  
2